These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35075772)

  • 1. Genes regulated by DNA methylation are involved in distinct phenotypes during melanoma progression and are prognostic factors for patients.
    Papaiz DD; Rius FE; Ayub ALP; Origassa CS; Gujar H; Pessoa DO; Reis EM; Nsengimana J; Newton-Bishop J; Mason CE; Weisenberger DJ; Liang G; Jasiulionis MG
    Mol Oncol; 2022 May; 16(9):1913-1930. PubMed ID: 35075772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival.
    Rius FE; Papaiz DD; Azevedo HFZ; Ayub ALP; Pessoa DO; Oliveira TF; Loureiro APM; Andrade F; Fujita A; Reis EM; Mason CE; Jasiulionis MG
    Clin Epigenetics; 2022 May; 14(1):68. PubMed ID: 35606887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic reprogramming as a key contributor to melanocyte malignant transformation.
    Molognoni F; Cruz AT; Meliso FM; Morais AS; Souza CF; Xander P; Bischof JM; Costa FF; Soares MB; Liang G; Jones PA; Jasiulionis MG
    Epigenetics; 2011 Apr; 6(4):450-64. PubMed ID: 21343701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation.
    Gasque Schoof CR; Izzotti A; Jasiulionis MG; Vasques Ldos R
    Biomed Res Int; 2015; 2015():634749. PubMed ID: 26618174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis.
    de Souza CF; Xander P; Monteiro AC; Silva AG; da Silva DC; Mai S; Bernardo V; Lopes JD; Jasiulionis MG
    PLoS One; 2012; 7(9):e44800. PubMed ID: 22984562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression.
    Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG
    Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma.
    Hallberg AR; Vorrink SU; Hudachek DR; Cramer-Morales K; Milhem MM; Cornell RA; Domann FE
    Epigenetics; 2014 Dec; 9(12):1641-7. PubMed ID: 25625848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment.
    Seftor EA; Brown KM; Chin L; Kirschmann DA; Wheaton WW; Protopopov A; Feng B; Balagurunathan Y; Trent JM; Nickoloff BJ; Seftor RE; Hendrix MJ
    Cancer Res; 2005 Nov; 65(22):10164-9. PubMed ID: 16288000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis.
    Azevedo H; Pessoa GC; de Luna Vitorino FN; Nsengimana J; Newton-Bishop J; Reis EM; da Cunha JPC; Jasiulionis MG
    Clin Epigenetics; 2020 Aug; 12(1):127. PubMed ID: 32831131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.
    Fröhlich A; Sirokay J; Fietz S; Vogt TJ; Dietrich J; Zarbl R; Florin M; Kuster P; Saavedra G; Valladolid SR; Hoffmann F; Flatz L; Ring SS; Golletz C; Pietsch T; Strieth S; Brossart P; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
    EBioMedicine; 2020 Sep; 59():102962. PubMed ID: 32861198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of mGluR1 expression in human melanocytes and melanoma cells.
    Lee HJ; Wall BA; Wangari-Talbot J; Chen S
    Biochim Biophys Acta; 2012; 1819(11-12):1123-31. PubMed ID: 22771868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation.
    Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG
    Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
    Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
    Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.
    Hoek K; Rimm DL; Williams KR; Zhao H; Ariyan S; Lin A; Kluger HM; Berger AJ; Cheng E; Trombetta ES; Wu T; Niinobe M; Yoshikawa K; Hannigan GE; Halaban R
    Cancer Res; 2004 Aug; 64(15):5270-82. PubMed ID: 15289333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras and Rac1, frequently mutated in melanomas, are activated by superoxide anion, modulate Dnmt1 level and are causally related to melanocyte malignant transformation.
    Molognoni F; de Melo FH; da Silva CT; Jasiulionis MG
    PLoS One; 2013; 8(12):e81937. PubMed ID: 24358134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?
    Gilhooly EM; Morse-Gaudio M; Bianchi L; Reinhart L; Rose DP; Connolly JM; Reed JA; Albino AP
    Melanoma Res; 2001 Aug; 11(4):355-69. PubMed ID: 11479424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA hypermethylation is associated with invasive phenotype of malignant melanoma.
    Koroknai V; Szász I; Hernandez-Vargas H; Fernandez-Jimenez N; Cuenin C; Herceg Z; Vízkeleti L; Ádány R; Ecsedi S; Balázs M
    Exp Dermatol; 2020 Jan; 29(1):39-50. PubMed ID: 31602702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-type-specific meQTLs extend melanoma GWAS annotation beyond eQTLs and inform melanocyte gene-regulatory mechanisms.
    Zhang T; Choi J; Dilshat R; Einarsdóttir BÓ; Kovacs MA; Xu M; Malasky M; Chowdhury S; Jones K; Bishop DT; Goldstein AM; Iles MM; Landi MT; Law MH; Shi J; Steingrímsson E; Brown KM
    Am J Hum Genet; 2021 Sep; 108(9):1631-1646. PubMed ID: 34293285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.
    Cheng PF; Shakhova O; Widmer DS; Eichhoff OM; Zingg D; Frommel SC; Belloni B; Raaijmakers MI; Goldinger SM; Santoro R; Hemmi S; Sommer L; Dummer R; Levesque MP
    Genome Biol; 2015 Feb; 16(1):42. PubMed ID: 25885555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA Methylation and Uveal Melanoma.
    Yang ZK; Yang JY; Xu ZZ; Yu WH
    Chin Med J (Engl); 2018 Apr; 131(7):845-851. PubMed ID: 29578129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.